# NCR Atleos Corp: financial statements, quarterly

NATL · NYSE · CIK 1974138 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/natl.md) · [Financials](/companies/natl/financials.md) · [Filings](/companies/natl/filings.md) · [Insiders](/companies/natl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/natl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,065](/filings/0001628280-25-049577.md) | [1,096](/filings/0001628280-25-049577.md) | [1,046](/filings/0001628280-25-049577.md) | [1,078](/filings/0001628280-25-049577.md) | [1,073](/filings/0001628280-25-050175.md) | [1,108](/filings/0001628280-25-049577.md) | [979](/filings/0001974138-26-000009.md) | [1,102](/filings/0001974138-26-000016.md) | [1,121](/filings/0001628280-26-012576.md) | [1,152](/filings/0001628280-26-012576.md) | [1,043](/filings/0001974138-26-000009.md) | [1,103](/filings/0001974138-26-000016.md) |
| Research and development | $m | [17.0](/filings/0001628280-25-049577.md) | [26.0](/filings/0001628280-25-049577.md) | [17.0](/filings/0001974138-25-000024.md) | [11.0](/filings/0001628280-25-049577.md) | [15.0](/filings/0001628280-25-050175.md) | [19.0](/filings/0001628280-25-049577.md) | [17.0](/filings/0001974138-26-000009.md) | [17.0](/filings/0001974138-26-000016.md) | [18.0](/filings/0001628280-26-012576.md) | [18.0](/filings/0001628280-26-012576.md) | [20.0](/filings/0001974138-26-000009.md) | [20.0](/filings/0001974138-26-000016.md) |
| Selling, general and administrative | $m | [160](/filings/0001974138-24-000062.md) | [140](/filings/0001628280-25-049577.md) | [132](/filings/0001974138-25-000024.md) | [132](/filings/0001974138-25-000039.md) | [127](/filings/0001628280-25-050175.md) | [130](/filings/0001628280-25-049577.md) | [122](/filings/0001974138-26-000009.md) | [116](/filings/0001974138-26-000016.md) | [143](/filings/0001628280-26-012576.md) | [132](/filings/0001628280-26-012576.md) | [130](/filings/0001974138-26-000009.md) | [133](/filings/0001974138-26-000016.md) |
| Operating income | $m | [90.0](/filings/0001628280-25-049577.md) | [30.0](/filings/0001628280-25-049577.md) | [68.0](/filings/0001628280-25-049577.md) | [106](/filings/0001628280-25-049577.md) | [114](/filings/0001628280-25-050175.md) | [149](/filings/0001628280-25-049577.md) | [93.0](/filings/0001974138-26-000009.md) | [119](/filings/0001974138-26-000016.md) | [110](/filings/0001628280-26-012576.md) | [156](/filings/0001628280-26-012576.md) | [84.0](/filings/0001974138-26-000009.md) | [156](/filings/0001974138-26-000016.md) |
| Interest expense | $m | [6.0](/filings/0001974138-24-000062.md) | [75.0 d](/filings/0001628280-26-012576.md) | [79.0](/filings/0001974138-25-000024.md) | [79.0](/filings/0001974138-25-000039.md) | [79.0](/filings/0001628280-25-050175.md) | [72.0 d](/filings/0001628280-26-012576.md) | [67.0](/filings/0001974138-26-000009.md) | [69.0](/filings/0001974138-26-000016.md) | [68.0](/filings/0001628280-26-012576.md) | [66.0](/filings/0001628280-26-012576.md) | [63.0](/filings/0001974138-26-000009.md) | [62.0](/filings/0001974138-26-000016.md) |
| Income tax | $m | [146](/filings/0001628280-25-049577.md) | [44.0](/filings/0001628280-25-049577.md) | [3.0](/filings/0001628280-25-049577.md) | [5.0](/filings/0001628280-25-049577.md) | [10.0](/filings/0001628280-25-050175.md) | [26.0](/filings/0001628280-25-049577.md) | [9.0](/filings/0001974138-26-000009.md) | [19.0](/filings/0001974138-26-000016.md) | [7.0](/filings/0001628280-26-012576.md) | [(8.0)](/filings/0001628280-26-012576.md) | [11.0](/filings/0001974138-26-000009.md) | [25.0](/filings/0001974138-26-000016.md) |
| Net income | $m | [(61.0)](/filings/0001628280-25-049577.md) | [(175)](/filings/0001628280-25-049577.md) | [(9.0)](/filings/0001628280-25-049577.md) | [27.0](/filings/0001628280-25-049577.md) | [21.0](/filings/0001628280-25-050175.md) | [41.0](/filings/0001628280-25-049577.md) | [14.0](/filings/0001974138-26-000009.md) | [39.0](/filings/0001974138-26-000016.md) | [26.0](/filings/0001628280-26-012576.md) | [83.0](/filings/0001628280-26-012576.md) | [22.0](/filings/0001974138-26-000009.md) | [65.0](/filings/0001974138-26-000016.md) |
| Diluted EPS | $ per share | [(0.86)](/filings/0001628280-25-049577.md) | [(2.48)](/filings/0001628280-25-049577.md) | [(0.13)](/filings/0001628280-25-049577.md) | [0.37](/filings/0001628280-25-049577.md) | [0.28](/filings/0001628280-25-050175.md) | [0.55](/filings/0001628280-25-049577.md) | [0.19](/filings/0001974138-26-000009.md) | [0.52](/filings/0001974138-26-000016.md) | [0.34](/filings/0001628280-26-012576.md) | [1.09](/filings/0001628280-26-012576.md) | [0.29](/filings/0001974138-26-000009.md) | [0.86](/filings/0001974138-26-000016.md) |
| Basic EPS | $ per share | [(0.86)](/filings/0001628280-25-049577.md) | [(2.48)](/filings/0001628280-25-049577.md) | [(0.13)](/filings/0001628280-25-049577.md) | [0.37](/filings/0001628280-25-049577.md) | [0.29](/filings/0001628280-25-050175.md) | [0.57](/filings/0001628280-25-049577.md) | [0.19](/filings/0001974138-26-000009.md) | [0.53](/filings/0001974138-26-000016.md) | [0.35](/filings/0001628280-26-012576.md) | [1.13](/filings/0001628280-26-012576.md) | [0.30](/filings/0001974138-26-000009.md) | [0.88](/filings/0001974138-26-000016.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [423](/filings/0001974138-24-000062.md) | [339](/filings/0001628280-26-012576.md) | [343](/filings/0001974138-25-000024.md) | [374](/filings/0001974138-25-000039.md) | [395](/filings/0001628280-25-050175.md) | [419](/filings/0001628280-26-012576.md) | [352](/filings/0001974138-26-000009.md) | [355](/filings/0001974138-26-000016.md) | [412](/filings/0001628280-25-050175.md) | [456](/filings/0001974138-26-000016.md) | [433](/filings/0001974138-26-000009.md) | [429](/filings/0001974138-26-000016.md) |
| Current assets | $m | [1,901](/filings/0001974138-23-000023.md) | [1,861](/filings/0001628280-25-049577.md) | [1,983](/filings/0001974138-24-000029.md) | [1,979](/filings/0001974138-24-000049.md) | [1,931](/filings/0001974138-24-000062.md) | [1,749](/filings/0001628280-26-012576.md) | [1,937](/filings/0001974138-25-000024.md) | [1,976](/filings/0001974138-25-000039.md) | [1,817](/filings/0001628280-25-050175.md) | [1,824](/filings/0001974138-26-000016.md) | [1,815](/filings/0001974138-26-000009.md) | [1,848](/filings/0001974138-26-000016.md) |
| Total assets | $m | [8,309](/filings/0001974138-23-000023.md) | [5,702](/filings/0001628280-25-049577.md) | [5,776](/filings/0001974138-24-000029.md) | [5,765](/filings/0001974138-24-000049.md) | [5,748](/filings/0001974138-24-000062.md) | [5,535](/filings/0001628280-26-012576.md) | [5,739](/filings/0001974138-25-000024.md) | [5,814](/filings/0001974138-25-000039.md) | [5,650](/filings/0001628280-25-050175.md) | [5,668](/filings/0001974138-26-000016.md) | [5,641](/filings/0001974138-26-000009.md) | [5,664](/filings/0001974138-26-000016.md) |
| Current liabilities | $m | [1,561](/filings/0001974138-23-000023.md) | [1,773](/filings/0001628280-25-049577.md) | [1,883](/filings/0001974138-24-000029.md) | [1,853](/filings/0001974138-24-000049.md) | [1,799](/filings/0001974138-24-000062.md) | [1,722](/filings/0001628280-26-012576.md) | [1,888](/filings/0001974138-25-000024.md) | [1,887](/filings/0001974138-25-000039.md) | [1,784](/filings/0001628280-25-050175.md) | [1,899](/filings/0001974138-26-000016.md) | [1,851](/filings/0001974138-26-000009.md) | [1,802](/filings/0001974138-26-000016.md) |
| Total liabilities | $m | [4,719](/filings/0001974138-23-000023.md) | [5,480](/filings/0001628280-25-049577.md) | [5,489](/filings/0001974138-24-000029.md) | [5,514](/filings/0001974138-24-000049.md) | [5,486](/filings/0001974138-24-000062.md) | [5,312](/filings/0001628280-26-012576.md) | [5,461](/filings/0001974138-25-000024.md) | [5,462](/filings/0001974138-25-000039.md) | [5,319](/filings/0001628280-25-050175.md) | [5,266](/filings/0001974138-26-000016.md) | [5,245](/filings/0001974138-26-000009.md) | [5,200](/filings/0001974138-26-000016.md) |
| Long-term debt | $m | not reported | [2,938](/filings/0001628280-25-049577.md) | [2,857](/filings/0001974138-24-000029.md) | [2,921](/filings/0001974138-24-000049.md) | [2,906](/filings/0001974138-24-000062.md) | [2,859](/filings/0001628280-26-012576.md) | [2,833](/filings/0001974138-25-000024.md) | [2,816](/filings/0001974138-25-000039.md) | [2,789](/filings/0001628280-25-050175.md) | [2,672](/filings/0001974138-26-000016.md) | [2,703](/filings/0001974138-26-000009.md) | [2,711](/filings/0001974138-26-000016.md) |
| Current portion of debt | $m | not reported | [76.0](/filings/0001628280-25-049577.md) | [80.0](/filings/0001974138-24-000029.md) | [84.0](/filings/0001974138-24-000049.md) | [88.0](/filings/0001974138-24-000062.md) | [81.0](/filings/0001628280-26-012576.md) | [81.0](/filings/0001974138-25-000024.md) | [81.0](/filings/0001974138-25-000039.md) | [80.0](/filings/0001628280-25-050175.md) | [86.0](/filings/0001974138-26-000016.md) | [80.0](/filings/0001974138-26-000009.md) | [84.0](/filings/0001974138-26-000016.md) |
| Shareholders' equity | $m | [3,590](/filings/0001974138-23-000023.md) | [219](/filings/0001628280-25-049577.md) | [283](/filings/0001974138-24-000029.md) | [250](/filings/0001974138-24-000049.md) | [264](/filings/0001974138-24-000062.md) | [219](/filings/0001628280-26-012576.md) | [275](/filings/0001974138-25-000024.md) | [350](/filings/0001974138-25-000039.md) | [330](/filings/0001628280-25-050175.md) | [403](/filings/0001974138-26-000016.md) | [396](/filings/0001974138-26-000009.md) | [464](/filings/0001974138-26-000016.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [147 d](/filings/0001974138-24-000062.md) | [8.0 d](/filings/0001628280-26-012576.md) | [148](/filings/0001974138-25-000024.md) | [9.0 d](/filings/0001974138-25-000039.md) | [107 d](/filings/0001628280-25-050175.md) | [80.0 d](/filings/0001628280-26-012576.md) | [123](/filings/0001974138-26-000009.md) | [(25.0) d](/filings/0001974138-26-000016.md) | [27.0 d](/filings/0001628280-25-050175.md) | [231 d](/filings/0001628280-26-012576.md) | [(9.0)](/filings/0001974138-26-000009.md) | [30.0 d](/filings/0001974138-26-000016.md) |
| Capital expenditure | $m | [48.0 d](/filings/0001974138-24-000062.md) | [38.0 d](/filings/0001628280-26-012576.md) | [24.0](/filings/0001974138-25-000024.md) | [23.0 d](/filings/0001974138-25-000039.md) | [22.0 d](/filings/0001628280-25-050175.md) | [18.0 d](/filings/0001628280-26-012576.md) | [29.0](/filings/0001974138-26-000009.md) | [21.0 d](/filings/0001974138-26-000016.md) | [30.0 d](/filings/0001628280-25-050175.md) | [37.0 d](/filings/0001628280-26-012576.md) | [27.0](/filings/0001974138-26-000009.md) | [26.0 d](/filings/0001974138-26-000016.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001974138-26-000009.md) | [0.0 d](/filings/0001974138-26-000016.md) | not reported | not reported | [16.0](/filings/0001974138-26-000009.md) | [0.0 d](/filings/0001974138-26-000016.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [70.6](/filings/0001628280-25-049577.md) | [70.6](/filings/0001628280-25-049577.md) | [71.6](/filings/0001628280-25-049577.md) | [73.7](/filings/0001628280-25-049577.md) | [74.5](/filings/0001628280-25-050175.md) | [75.0](/filings/0001628280-25-049577.md) | [75.2](/filings/0001974138-26-000009.md) | [74.9](/filings/0001974138-26-000016.md) | [76.0](/filings/0001628280-26-012576.md) | [76.3](/filings/0001628280-26-012576.md) | [75.6](/filings/0001974138-26-000009.md) | [75.8](/filings/0001974138-26-000016.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 73,896,934 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001974138-26-000016.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.